[Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
D000527:Alprostadil / Q000031:analogs & derivatives / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001101:Arbaprostil / Q000627:therapeutic use; D015232:Dinoprostone / Q000031:analogs & derivatives*; D016620:Enprostil; D006801:Humans; D016595:Misoprostol; D010437:Peptic Ulcer / Q000188:drug therapy*; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D011459:Prostaglandins E, Synthetic; D016595:Misoprostol; C038879:trimoprostil; D000527:Alprostadil; D016620:Enprostil; D015232:Dinoprostone; D001101:Arbaprostil